Quercetin effectiveness in patients with COVID-19 associated pneumonia
I A Zupanets, О А Holubovska, O O Tarasenko, N P Bezuhla, M F Pasichnyk, S O Karabynosh, V S Kopcha, L V Moroz, H V Maksymchuk, O Ya. Kobrynska, R M Fishchuk, D I Schulha, R S Morochkovskyj, M S Zoshchak
Zaporozhye Medical Journal, doi:10.14739/2310-1210.2021.5.231714
The aim of this work was to evaluate the effectiveness of quercetin addition to the treatment regimen for patients with COVID-19 associated pneumonia.
Materials and methods. The effectiveness of two dosage forms of quercetin was studied in 200 patients, who were divided equally into the main and control groups. The main group patients received quercetin in addition to the basic therapy: intravenous drip of Quercetin/Polyvinylirolidone during the first 10 days followed by oral administration of Quercetin/Pectin over the next 10 days. Patients from the control group received only the basic therapy drugs. The study evaluated the dynamics of the disease symptoms (saturation level, respiratory rate, body temperature, cough, general weakness), as well as laboratory markers (C-reactive protein (CRP), ferritin, D-dimer). Results. Two dosage forms of quercetin consistently used in addition to the basic therapy improve pulmonary gas exchange and accelerate the lung function recovery. This is evidenced by a statistically significant majority of patients with positive dynamics in the symptoms of "Saturation level" and "Cough" as well as the meeting a complex indicator of the therapy effectiveness 2 days earlier than in the control group. The treatment regimen applied also helps to stabilize the level of D-dimer in the blood of the main group patients. Conclusions. The use of two dosage forms of quercetin in addition to the basic therapy accelerates the recovery of patients with coronavirus disease associated pneumonia and can help to prevent the progression of COVID-19 associated coagulopathy.
References
Ascierto, Fu, Wei, IL-6 modulation for COVID-19: the right patients at the right time?, Journal for Immuno-Therapy of Cancer,
doi:10.1136/jitc-2020-002285Ascierto, Fu, Wei, IL-6 modulation for COVID-19: the right patients at the right time?, Journal for ImmunoTherapy of Cancer,
doi:10.1136/jitc-2020-002285Chornomydz, Kliniko-patohenetychne obgruntuvannia zastosuvannia kvertsytynu u kompleksnomu likuvanni ditei iz hostroiu pozalikarnianoiu pnevmoniieiu [Clinical and nosotropic ground of application of quercetin in complex treatment of children with acute extrahospital pneumonia
Fda, FDA Approves First Treatment for COVID-19
Fedortsiv, Ye, Chornomydz, Behosh, Klinichna efektyvnist vykorystannia kvertsetynu u kompleksnomu likuvanni ditei, khvorykh na pozalikarnianu pnevmoniiu [Clinical efficiency quercetin in complex treatment of children with community-acquired pneumonia
Griffiths, Mcauley, Perkins, Barrett, Blackwood et al., Guidelines on the management of acute respiratory distress syndrome, BMJ Open Respiratory Research,
doi:10.1136/bmjresp-2019-000420Marik, EVMS critical care COVID-19 management protocol
Marik, EVMS critical care COVID-19 management protocol
Metlay, Waterer, Treatment of Community-Acquired Pneumonia During the Coronavirus Disease
Metlay, Waterer, Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pan, Annals of Internal Medicine,
doi:10.7326/M20-2189Parkhomenko, Kozhukhov, investigate the tolerability and efficacy of Corvitin® in patients with congestive heart failure and left ventricular systolic dysfunction
Singh, Ryan, Kredo, Chaplin, Fletcher, Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19, Cochrane Database of Systematic Reviews,
doi:10.1002/14651858.CD013587.pub2Usenko, Zupanets, Tarasenko, Shebeko, Eksperymentalne doslidzhennia farmakokinetychnykh vlastyvostei kvertsetynu pry peroralnomu zastosuvanni z modyfikatoramy rozchynnosti [Experimental study of pharmacokinetic properties of quercetin at oral apрlication with modifiers of solubility, Medychna i klinichna khimiia
Xiao, Shi, Liu, Wang, Xie et al., Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling, PLOS ONE,
doi:10.1371/journal.pone.0022934Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, The Lancet,
doi:10.1016/S0140-6736(20)30566-3Zhoui, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, The Lancet,
doi:10.1016/S0140-6736(20)30566-3Безугла, доцент каф. клінічної фармакології та клінічної фармації, Національний фармацевтичний університет, м. Харків, Україна
Відомості, Зупанець, р мед. наук, професор каф. клінічної фармакології та клінічної фармації, Національний фармацевтичний університет, м
Голубовська, Д-Р Мед. Наук, професор, зав. каф. інфекційних хвороб, Національний медичний університет імені
Максимчук, Рівне, MD, Infectious Disease Physician of the Department for Adults, Municipal Non-Commercial Enterprise
Мороз, Д-Р, мед. наук, професор каф. інфекційних хвороб з курсом епідеміології, Вінницький національний медичний університет імені М
Морочковский, врач-инфекционист инфекционного отделения, КНП «Ирпенская центральная городская больница» Ирпенского городского совета Киевской области, Украина. Список літератури
Пархоменко, Кожухов, Результаты открытого рандомизированного исследования по изучению переносимости и эффективности препарата Корвитин® у пациентов с застойной сердечной недостаточностью и систолической дисфункцией левого желудочка, Український медичний часопис
Пасічник, Наук, генеральний директор ПАТ НВЦ «Борщагівський ХФЗ
Тарасенко, доцент каф. клінічної фармакології та клінічної фармації, Національний фармацевтичний університет, м. Харків, Україна
Федорців, Чорномидз, Бегош, Клінічна ефективність використання кверцетину у комплексному лікуванні дітей, хворих на позалікарняну пневмонію. Актуальні питання педіатрії, акушерства та гінекології
Чорномидз, Клініко-патогенетичне обґрунтування застосування кверцитину у комплексному лікуванні дітей із гострою позалікарняною пневмонією, Вісник наукових досліджень
{ 'indexed': { 'date-parts': [[2023, 11, 17]],
'date-time': '2023-11-17T00:39:50Z',
'timestamp': 1700181590087},
'reference-count': 0,
'publisher': 'Zaporozhye State Medical University',
'issue': '5',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>The aim of this work was to evaluate the\xa0effectiveness of quercetin addition to '
'the\xa0treatment regimen for patients with COVID-19 associated pneumonia.\n'
'Materials and methods. The effectiveness of two dosage forms of quercetin was studied in 200 '
'patients, who were divided equally into the\xa0main and control groups. The main group '
'patients received quercetin in addition to the\xa0basic therapy: intravenous drip of '
'Quercetin/Polyvinylirolidone during the\xa0first 10 days followed by oral administration of '
'Quercetin/Pectin over the\xa0next 10 days. Patients from the\xa0control group received only '
'the\xa0basic therapy drugs. \n'
'The study evaluated the\xa0dynamics of the\xa0disease symptoms (saturation level, respiratory '
'rate, body temperature, cough, general weakness), as well as laboratory markers (C-reactive '
'protein (CRP), ferritin, D-dimer).\n'
'Results. Two dosage forms of quercetin consistently used in addition to the\xa0basic therapy '
'improve pulmonary gas exchange and accelerate the\xa0lung function recovery. This is '
'evidenced by a statistically significant majority of patients with positive dynamics in '
'the\xa0symptoms of “Saturation level” and “Cough” as well as the\xa0meeting a complex '
'indicator of the\xa0therapy effectiveness 2 days earlier than in the\xa0control group. The '
'treatment regimen applied also helps to stabilize the\xa0level of D-dimer in the\xa0blood of '
'the\xa0main group patients.\n'
'Conclusions. The use of two dosage forms of quercetin in addition to the\xa0basic therapy '
'accelerates the\xa0recovery of patients with coronavirus disease associated pneumonia and can '
'help to prevent the\xa0progression of COVID-19 associated coagulopathy.</jats:p>',
'DOI': '10.14739/2310-1210.2021.5.231714',
'type': 'journal-article',
'created': {'date-parts': [[2022, 1, 10]], 'date-time': '2022-01-10T15:40:29Z', 'timestamp': 1641829229000},
'page': '636-643',
'source': 'Crossref',
'is-referenced-by-count': 3,
'title': 'Quercetin effectiveness in patients with COVID-19 associated pneumonia',
'prefix': '10.14739',
'volume': '23',
'author': [ { 'ORCID': 'http://orcid.org/0000-0003-1253-9217',
'authenticated-orcid': False,
'given': 'I. A.',
'family': 'Zupanets',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-3455-8718',
'authenticated-orcid': False,
'given': 'О. А.',
'family': 'Holubovska',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-8454-1829',
'authenticated-orcid': False,
'given': 'O. O.',
'family': 'Tarasenko',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-6420-2547',
'authenticated-orcid': False,
'given': 'N. P.',
'family': 'Bezuhla',
'sequence': 'additional',
'affiliation': []},
{'given': 'M. F.', 'family': 'Pasichnyk', 'sequence': 'additional', 'affiliation': []},
{'given': 'S. O.', 'family': 'Karabynosh', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0001-9499-3733',
'authenticated-orcid': False,
'given': 'V. S.',
'family': 'Kopcha',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-7111-3155',
'authenticated-orcid': False,
'given': 'L. V.',
'family': 'Moroz',
'sequence': 'additional',
'affiliation': []},
{'given': 'H. V.', 'family': 'Maksymchuk', 'sequence': 'additional', 'affiliation': []},
{'given': 'O. Ya.', 'family': 'Kobrynska', 'sequence': 'additional', 'affiliation': []},
{'given': 'R. M.', 'family': 'Fishchuk', 'sequence': 'additional', 'affiliation': []},
{'given': 'D. I.', 'family': 'Schulha', 'sequence': 'additional', 'affiliation': []},
{'given': 'R. S.', 'family': 'Morochkovskyj', 'sequence': 'additional', 'affiliation': []},
{'given': 'M. S.', 'family': 'Zoshchak', 'sequence': 'additional', 'affiliation': []}],
'member': '7452',
'published-online': {'date-parts': [[2021, 9, 1]]},
'container-title': 'Zaporozhye Medical Journal',
'original-title': [],
'link': [ { 'URL': 'http://zmj.zsmu.edu.ua/article/download/231714/239305',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'http://zmj.zsmu.edu.ua/article/download/231714/239305',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 1, 10]],
'date-time': '2022-01-10T15:41:33Z',
'timestamp': 1641829293000},
'score': 1,
'resource': {'primary': {'URL': 'http://zmj.zsmu.edu.ua/article/view/231714'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 9, 1]]},
'references-count': 0,
'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2021, 10, 1]]}},
'URL': 'http://dx.doi.org/10.14739/2310-1210.2021.5.231714',
'relation': {},
'ISSN': ['2310-1210', '2306-4145'],
'container-title-short': 'ZMJ',
'published': {'date-parts': [[2021, 9, 1]]}}
